Results 1 to 10 of about 16,961 (264)

Danazol

Reactions Weekly, 1992
openaire   +1 more source

Danazol

Reactions, 1989
openaire   +1 more source

Danazol

Reactions, 1984
openaire   +1 more source

Danazol.

Nursing times, 2005
openaire   +1 more source

Delphi Consensus on Attenuated Androgen Use for Long-Term Prophylaxis in Hereditary Angioedema: AURA Project. [PDF]

Clin Transl Allergy
Background Danazol and other attenuated androgens (AAs) have been a cornerstone of Hereditary Angioedema (HAE) long‐term prophylaxis (LTP) for decades, alongside intravenous plasma‐derived C1INH (pdC1INH). Danazol's potential androgenic effects, however,
Dias de Castro E, Cardoso LM, Jácome de Castro J, Ferreira MB.   +3 more
europepmc   +3 more sources

Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM. [PDF]

Future Oncol
Aim: To estimate projected US-based cost and time burden for patients with myelofibrosis and anemia treated with momelotinib compared with danazol. Methods: Cost and time burden were calculated based on the transfusion status of patients in the MOMENTUM ...
Masarova L, Verstovsek S, Liu T, Rao S, Sajeev G, Fillbrunn M, Simpson R, Li W, Yang J, Le Lorier Y, Gorsh B, Signorovitch J.   +11 more
europepmc   +4 more sources

No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis

ERJ Open Research, 2023
Background Telomere dysfunction can underly the development of idiopathic pulmonary fibrosis (IPF), and recent work suggests that patients with telomere syndromes might benefit from treatment with androgens, such as danazol.
T. Hoffman, C. van Moorsel, J. J. van der Vis, Douwe H Biesma, J. Grutters   +4 more
semanticscholar   +3 more sources

Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review

Pharmaceuticals, 2022
Danazol is a treatment option for autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Three patients with AIHA and eight patients with ITP between 2008 and 2022 were enrolled in the Rheumatology Outpatient Clinic of Chang Gung Memorial ...
Hsuen-En Huang, Ko-Ming Lin, Jing-Chi Lin, Yu-Ting Lin, Hsiao-Ru He, Yu-wei Wang, Shan-Fu Yu, Jia-Feng Chen, T. Cheng   +8 more
semanticscholar   +3 more sources

TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis

BMJ Open Respiratory Research, 2021
Introduction Recent discoveries have identified shortened telomeres and related mutations in people with pulmonary fibrosis (PF). There is evidence to suggest that androgens, including danazol, may be effective in lengthening telomeres in peripheral ...
J. Mackintosh, M. Pietsch, Viviana P Lutzky, D. Enever, S. Bancroft, S. Apte, M. Tan, S. Yerkovich, J. Dickinson, H. Pickett, H. Selvadurai, C. Grainge, N. Goh, P. Hopkins, I. Glaspole, P. Reynolds, J. Wrobel, A. Jaffe, T. Corte, D. Chambers   +19 more
semanticscholar   +3 more sources

Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells

Scientific Reports, 2019
Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MDR) cancer.
Ying-Tzu Chang, Yu-Ning Teng, Kun-I Lin, C. Wang, S. Morris-Natschke, K. Lee, Chin-Chuan Hung   +6 more
semanticscholar   +2 more sources